AI assistant
Sending…
LEMAITRE VASCULAR INC — Director's Dealing 2015
Sep 17, 2015
31708_dirs_2015-09-17_76d6bce0-51a8-4094-a56d-b6c1c980d354.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2015-09-15
Reporting Person: Pellegrino Joseph P JR (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-15 | Common Stock | M | 56595 | $3.00 | Acquired | 107337 | Direct |
| 2015-09-15 | Common Stock | M | 3052 | $4.70 | Acquired | 110389 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-15 | Stock Option (Right to Buy) | $3.00 | M | 56595 | Disposed | 2016-07-27 | Common Stock (56595) | Direct |
| 2015-09-15 | Stock Option (Right to Buy) | $4.70 | M | 3052 | Disposed | 2017-02-25 | Common Stock (3052) | Direct |
Footnotes
F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2: This option is fully vested and exercisable.
More from LEMAITRE VASCULAR INC
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Apr 14
Annual Report
2026
Apr 14
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3